Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant …

P Kopschina Feltes, J Doorduin… - Journal of …, 2017 - journals.sagepub.com
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disease with rates
of non-responsiveness to antidepressants ranging from 30–50%. Historically, the …

The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder

YK Kim, E Won - Behavioural brain research, 2017 - Elsevier
Major depressive disorder (MDD) is a condition which has often been associated with
chronic stress. The sympathetic nervous system is continuously activated without the normal …

Clinical management of pediatric acute-onset neuropsychiatric syndrome: part II—use of immunomodulatory therapies

J Frankovich, S Swedo, T Murphy, RC Dale… - Journal of child and …, 2017 - liebertpub.com
Abstract Introduction: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a
clinically heterogeneous disorder with a number of different etiologies and disease …

[HTML][HTML] Therapeutic implications of brain–immune interactions: treatment in translation

AH Miller, E Haroon, JC Felger - Neuropsychopharmacology, 2017 - nature.com
A wealth of data has been amassed that details a complex, yet accessible, series of
pathways by which the immune system, notably inflammation, can influence the brain and …

Anti-inflammatory treatments for mood disorders: systematic review and meta-analysis

MI Husain, R Strawbridge… - Journal of …, 2017 - journals.sagepub.com
Background: Recent studies suggest that anti-inflammatory medication may play a role in
the treatment of mood disorders. Aims: The purpose of this study was to determine the …

Inflammation effects on brain glutamate in depression: mechanistic considerations and treatment implications

E Haroon, AH Miller - Inflammation-associated depression: Evidence …, 2017 - Springer
There has been increasing interest in the role of glutamate in mood disorders, especially
given the profound effect of the glutamate receptor antagonist ketamine in improving …

Evidence for inflammation-associated depression

CS Liu, A Adibfar, N Herrmann, D Gallagher… - Inflammation-associated …, 2017 - Springer
This chapter explores the evidence supporting inflammation-associated depression. Data to
date suggest a bidirectional relationship between inflammation and depression wherein one …

Immunological aspects of the treatment of depression and schizophrenia

N Müller - Dialogues in clinical neuroscience, 2017 - Taylor & Francis
Schizophrenia and major depression (MD) have been associated with immune system
dysfunction. One example of this is the altered level of cytokines—important inflammatory …

Altered serum levels of TNF‐α, IL‐6, and IL‐18 in depressive disorder patients

N Fan, Y Luo, Y Ou, H He - … Psychopharmacology: Clinical and …, 2017 - Wiley Online Library
Objective Depressive disorder is associated with abnormal changes in cytokines levels. This
study aimed to assess serum concentrations of tumor necrosis factor (TNF) α, interleukin (IL) …

Association of inflammation with specific symptoms of depression in a general population of older people: The English Longitudinal Study of Ageing

J White, M Kivimäki, M Jokela, GD Batty - Brain, Behavior, and Immunity, 2017 - Elsevier
Elevated levels of inflammatory markers, such as C-reactive protein, are well documented in
people with depression. Few studies have examined whether the association between …